Details for New Drug Application (NDA): 007794
✉ Email this page to a colleague
NDA 007794 describes NEOTHYLLINE, which is a drug marketed by Teva and is included in two NDAs. Additional details are available on the NEOTHYLLINE profile page.
The generic ingredient in NEOTHYLLINE is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
The generic ingredient in NEOTHYLLINE is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
Summary for 007794
| Tradename: | NEOTHYLLINE |
| Applicant: | Teva |
| Ingredient: | dyphylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 007794
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 160MG/15ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
